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Abstract Bone marrow derived mesenchymal stro-
mal cells (BMSCs) are multipotent progenitors of
particular interest for cell-based tissue engineering
therapies. However, one disadvantage that limit their
clinical use is their heterogeneity. In the last decades a
great effort was made to select BMSC subpopulations
based on cell surface markers, however there is still no
general consensus on which markers to use to obtain
the best BMSCs for tissue regeneration. Looking for
alternatives we decided to focus on a probe-based
method to detect intracellular mRNA in living cells,
the SmartFlare technology. This technology does not
require fixation of the cells and allows us to sort living
cells based on gene expression into functionally
different populations. However, since the technology
is available it is debated whether the probes specifi-
cally recognize their target mRNAs. We validated the
TWIST1 probe and demonstrated that it specifically
recognizes TWIST1 in BMSCs. However, differences
in probe concentration, incubation time and cellular
uptake can strongly influence signal specificity. In
addition we found that TWIST1high expressing cells
have an increased expansion rate compared to
TWIST1low expressing cells derivedfrom the same
initial population of BMSCs. The SmartFlare probes
recognize their target gene, however for each probe
and cell type validation of the protocol is necessary.
Keywords Mesenchymal stem cells (MSCs) 
TWIST1  RNA probes  Tissue engineering  Cell
sorting  Expansion
Introduction
Multipotent progenitor cells from bone marrow aspi-
rates can differentiate into chondrocytes, osteoblasts
and adipocytes (Pittenger et al. 1999). These progen-
itor cells, often referred to as bone marrow-derived
mesenchymal stem or stromal cells (BMSCs), are
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appealing for cell-based tissue engineering purposes.
Unfortunately, their limited expansion capacity and
their heterogeneity, hinder their clinical use (Banfi
et al. 2000; Bonab et al. 2006; Chen et al. 2005; Li
et al. 2011). Several studies investigated cell surface
molecules to identify specific subpopulations of
BMSCs (Alvarez-Viejo et al. 2015; Buhring et al.
2007; Cleary et al. 2016; Delorme et al. 2008;
Sacchetti et al. 2007; Sivasubramaniyan et al. 2013).
However, despite the great effort, there is still no
general consensus on the surface markers that need to
be used to define or select the best BMSC subset for
tissue engineering. One drawback of surface markers
is that their function is often unknown, so alternative
markers are necessary to select cells according to their
function (Clevers and Watt 2018).
Recently, a probe-based method to detect intracel-
lular mRNA in living single cells has been developed,
the SmartFlare technology (Seferos et al. 2007;
Prigodich et al. 2009). The SmartFlare technique is a
promising tool to sort BMSCs into functionally
different populations. The SmartFlare probes are
taken up by the cells via endocytosis and if the target
mRNA is present, the probes bind to the target mRNA
and fluorescent reporters are released and
detectable (Figure S1A). Since the SmartFlare tech-
nology is available, this technique already success-
fully identified cancer cells (McClellan et al. 2015;
Kronig et al. 2015) and pluripotent stem cells (Lahm
et al. 2015). Additionally it was applied to investigate
a Nodal expressing subpopulation of melanoma cells
(Seftor et al. 2014), and to study a subpopulation of
human BMSCs with an enhanced osteogenic potential
(Li et al. 2016). However, other studies did not find a
correlation between the SmartFlare fluorescence
intensity and mRNA expression measured by RT-
PCR (Czarnek and Bereta 2017; Yang et al. 2018). In
addition, Czarnek et al. (2017) found that the
SmartFlare signal intensity correlates with the probe
uptake ability of the cells.
To assess if the SmartFlare technique can be used to
sort different populations of BMSCs based on gene
expression, we focused on the validation of a probe for
TWIST1. TWIST1 is a transcription factor that is
involved in the regulation of BMSC proliferation
(Goodnough et al. 2012; Isenmann et al. 2009; Tian
et al. 2015) and differentiation (Isenmann et al. 2009;
Boregowda et al. 2016; Cleary et al. 2017; Narcisi
et al. 2015, 2016). In the present study, we evaluated
the SmartFlare protocol in order to detect a specific
probe signal in our culture conditions and illustrated
that the SmartFlare fluorescence intensity is associated
with probe concentration, incubation time and cellular
uptake capacity.
Materials and methods
Isolation and culture of human adult bone marrow
mesenchymal stem cells
Human adult bone marrow aspirates were obtained
from femoral biopsies of 8 patients (22–79 years)
undergoing total hip replacement (MEC 2015-644,
MEC 2004-142: Erasmus Medical Center, Rotterdam;
MEC 2011.07 Albert Schweitzer Hospital, Dor-
drecht), after obtaining informed consent and full
ethical approval by the Erasmus MC and Albert
Schweitzer ethics committee.
Human BMSCs were isolated, seeded at the density
of 2300 cells/cm2 and cultured as previously described
in standard expansion media, containing 10% FCS
(Lonza, Verviers, Belgium; selected batch:1S016) and
1 ng/ml FGF2 (AbD Serotech, Kidlington, United
Kingdom) (Narcisi et al. 2016). The medium was
refreshed twice a week. BMSCs expanded for 3 to 6
passages were used for experiments.
SmartFlare probes
Cells were treated with the SmartFlare probe when
they were sub-confluent. SmartFlare probes TWIST1-
Cy3 (the only label available for TWIST1), Uptake-
Cy5, and GAPDH-Cy5 were purchased from Merck.
The probes were resuspended in 50 ll sterile nuclease
free water, 1:20 prediluted in PBS (Lonza) and added
to the cells with a final concentration of 50 pM or
100 pM. The cells were incubated for 6 or 16 h at
37 C and 5% CO2 and analyzed using flow cytom-
etry. To assure a broad range of TWIST1 gene
expression during the validation of the TWIST1-Cy3
probe, BMSCs from two different donors were mixed
and treated with the TWIST1-Cy3 probe.
Flow cytometry and FACS
Flow cytometry analysis was performed using a BD
Fortessa and the data was analyzed using FlowJo V10
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software. The cells were sorted using a BD Bio-
sciences FACS Aria and the data was analyzed using
BD FACS Diva 8.0.1 software. Cell debris were
excluded from the population through forward scatter
(FSC)/side scatter (SSC) gate and doublets were
excluded using FSC-A/FSC-H gate (Figure S2A). To
confirm effective sorting, the sorted populations were
reanalyzed (Figure S2B). Mean fluorescent intensity
(MFI) was measured using FlowJo V10 software. The
two different gates TWIST1high and TWISTlow were
established based on the TWIST1-Cy3 fluorescence
intensity, 15–25% of the extremes or two different
gates TWIST1/Uptakehigh and TWIST1/Uptakelowwere
established based on the TWIST1-Cy3 fluorescence
intensity, 15% of the extremes with a comparable
Uptake-Cy5 fluorescence intensity. The sorted cells
were collected in PBS with 1% FCS and reseeded with
a density of 2300 cells per cm2 or used for RNA
isolation.
Real time PCR analysis
Post-sorting, 200,000 BMSCs per sample were spun
down and treated on ice with RLT lysis buffer
(Qiagen, Hilden, Germany) with 1% b-mercap-
toethanol. BMSCs in monolayer were washed with
PBS and treated on ice with RLT lysis buffer (Qiagen)
with 1% b-mercaptoethanol. A range of 0.25–1.00 lg
of purified RNA (RNeasy Micro Kit; Qiagen) was
reverse transcribed into cDNA (RevertAid First Strand
cDNA Synthesis Kit; MBI Fermentas, St. Leon-Rot,
Germany). RT-PCR was performed using an anneal-
ing temperature of 60 C on a C1000 TouchTM
Thermal Cycler using SybrGreen (Eurogentec, Sera-
ing, Belgium). The data were normalized to the
housekeeper gene RSP27a. The relative expression
was calculated according to the 2-DDCt formula. The
primers used for RT-PCR are listed in (Table S1).
Data analysis
Linear correlation (Fig. 2c) was analyzed with
GraphPad Prism Software 5.00 assuming normal
distribution of the data.
Results
TWIST1 SmartFlare detects TWIST1 mRNA
after 6 h using a concentration of 50 pM in human
BMSCs
SmartFlare probes enter the cell via endocytosis and
this process can vary between different cell types
(Choi et al. 2013). The probe incubation time and
concentration which is suggested by the manufacturer
is 16 h and 100 pM. However we also included a 6 h
timepoint and a concentration of 50 pM in order to
verify whether or not it was possible to further
optimize the SmartFlare protocol for TWIST1 in
BMSCs. Interestingly, already after 6 h with a probe
concentration of 50 pM, 98.5% of the cells were
positive for TWIST1 SmartFlare signal (Fig. 1a;
lowest panel). No major differences in SmartFlare
signal intensity were observed between the different
probe concentrations and incubation times (Fig. 1a).
To study TWIST1-Cy3 signal specificity, BMSCs
were treated with TWIST1-Cy3 probe for 16 h or 6 h,
sorted based on the TWIST1-Cy3 signal by FACS and
subsequently tested by RT-PCR. Our FACS gating
strategy consisted of sorting 15% of the BMSCs with
the lowest TWIST1-Cy3 signal and 15% of the
BMSCs with the highest TWIST1-Cy3 signal
(TWIST1low vs TWIST1high; Fig. 1b). To our surprise
no difference in relative TWIST1 gene expression was
detected between TWIST1low and TWIST1high cells
after 16 h of probe incubation (Fig. 1c). This indicates
that although we observe a TWIST1 SmartFlare signal
after 16 h, this signal is probably not specific for
TWIST1 gene expression. However after 6 h incuba-
tion we confirmed that TWIST1high BMSCs have a
higher TWIST1 gene expression than the TWIST1low
population (6.25-fold difference; Fig. 1c). These data
shows that the TWIST1 probe specifically detects
TWIST1 gene expression in this population of BMSCs
already after 6 h incubation with a concentration of
50 pM probe. In addition we observed that more than
97.3% of cells were positive for the Uptake control
probe, a probe which is always fluorescent without
binding to a target (Supplementary Figure 1B), with
50 pM after 6 h of incubation.
To further determine the signal specificity of the
TWIST1 probe after 6 h, we analyzed the correlation
between the TWIST1-Cy3 signal intensity and
TWIST1 expression by RT-PCR. TWIST1 probe
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signal intensity from two BMSC populations (referred
to as donor 1 and donor 2) was measured using flow
cytometry, showing a higher intensity in donor 2 (8775
vs 5645 MFI; Fig. 2a). Transcript analysis confirmed
the difference in TWIST1 expression between the two
donors, showing a higher expression in donor 2
(Fig. 2b). We therefore repeated the analysis in four
other donors showing a positive and consistent
correlation between TWIST1-Cy3 probe intensity
and TWIST1 gene expression (r2 = 0.997; Fig. 2c).
These data again confirms that the TWIST1 probe
specifically targets the TWIST1 mRNA after 6 h of
incubation.
Correction for cellular probe uptake improves
TWIST1 gene detection
When we repeated the sorting experiment with other
donors not always differences in TWIST1 expression
by RT-PCR were observed between TWIST1low and
TWIST1high sorted cells (Figure S4). Given that, and
considering that Czarnek et al. recently showed that
Fig. 1 TWIST1 SmartFlare
probes are efficiently taken
up by BMSCs after 6 h.
a Flow cytometry histogram
of untreated BMSCs and
BMSCs with 100 pM or
50 pM TWIST1-Cy3 probe
incubated for 16 or 6 h, %
shows percentage Cy5
positive cells. b Gating
strategy based on TWIST1-
Cy3 intensity. The doted
graph represents unstained
BMSCs and the gray graph
represents BMSCs with
TWIST1-Cy3 probes.
c BMSCs were sorted based
on TWIST1-Cy3 intensity
after 16 and 6 h of probe
incubation. TWIST1
transcripts were analysis by
RT-PCR. Values represent
the mean ± SD from
duplicates or quadruplicate
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uptake capacity can influence the SmartFlare signal
specificity (Czarnek and Bereta 2017), we decided to
carefully monitor uptake in our BMSC populations.
To evaluate the effect of cellular uptake on the
TWIST1 signal, BMSCs from 4 different donors were
double labeled with TWIST1-Cy3 and Uptake-Cy5
probes (Figure S1B). At least 65% of the BMSCs were
able to take up both the TWIST1-Cy3 and Uptake-Cy5
probe (Fig. 3a) and we demonstrated that BMSCs
from different donors have a different uptake capacity
(Figure S5). Moreover, it is clear from the FACS
analysis that there is a general positive correlation
between Uptake-Cy5 signal and TWIST-Cy3 signal
(the higher the TWIST1 signal, the higher the Uptake
signal), although with variation between donors
(Fig. 3b and Figure S5). This indicates that in BMSCs
from different donors the TWIST1-Cy3 signal can be
affected by the cellular uptake capacity, with a degree
that depends on the individual uptake capacity of the
cells in the BMSC population. To determine whether
or not the detected differences in cellular uptake have
an effect on TWIST1 gene detection, BMSCs with a
high variation in Uptake-Cy5 fluorescence intensity
were treated with both TWIST1-Cy3 and Uptake-Cy5
probes and were sorted by FACS using two different
sorting strategies or left unsorted. In the first gating
strategy, similar to that previously used, 15% of the
BMSCs with the lowest TWIST1-Cy3 signal and 15%
of the BMSCs with the highest TWIST1-Cy3 signal
(TWIST1high) were sorted (Fig. 3c; left panel). In the
second gating strategy we corrected for the uptake
signal (Fig. 3d; left panel) by sorting TWIST1high and
TWIST1low cells with a minimal uptake variation.
Gene expression analysis showed no differences
between TWIST1low and TWIST1high populations in
the absence of uptake correction (Fig. 3c; left middle
panel), while a strong difference (13.3-fold) was
detected between the subpopulations where the
TWIST1 signal was corrected for the uptake (Fig. 3d;
left middle panel). These data indicate that differences
in cellular uptake can strongly influence TWIST1
detection using SmartFlare. In addition, we observed
that the sorted populations of BMSCs corrected for
cellular uptake had a similar cellular granularity
(Fig. 3c, d; right middle panel) and cell size (Fig. 3c,
d; right panel) compared to the populations sorted
without uptake correction.
TWIST1high BMSCs have a high expansion
capacity
In order to further validate our sorting strategy and
prove for the first time the pro-proliferative role of
TWIST1 in a subpopulation of BMSCs, we sorted
TWIST1high and TWIST1low cells and we compared
their expansion capacity post-sorting. RT-PCR con-
firmed that TWIST1high BMSCs had a higher relative
Fig. 2 TWIST1 SmartFlare detects TWIST1 mRNA expres-
sion. a Flow cytometry histogram of BMSCs from two donors
untreated or treated with the TWIST1-Cy3 probe for 6 h.
b TWIST1 RT-PCR results, values represent the mean ± SD
from triplicates. c Correlation between TWIST1 expression
measured by RT-PCR and TWIST1-Cy3 MFI. Dots represent
different donors (N = 4)
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TWIST1 gene expression than TWIST1low BMSCs
(1.6-fold difference; Fig. 4a). No evident differences
in morphology between TWIST1low and TWIST1high
were observed 5 days post sorting, while 16 days post
sorting TWIST1low BMSCs appeared more enlarged
compared to the TWIST1high BMSCs (Fig. 4b). More-
over, TWIST1high BMSCs showed a higher expansion
capacity than the TWIST1low population (Fig. 4c; 1.5-
Fig. 3 Correction for
cellular probe uptake
improves TWIST1 gene
detection. a Flow cytometry
plots of BMSCs of four
donors treated with both
TWIST1-Cy3 and Uptake-
Cy5 probe for 6 h (grey).
The perpendicular lines
represent the unstained
control (black) for each
donor. % shows percentage
Cy3 and Cy5 double
positive cells. b, c FACS
gating strategies using
TWIST1-Cy3 and Uptake-
Cy5 probes for 6 h and
TWIST1 RT-PCR results,
values represent the
mean ± SD from
duplicates. SSC-A MFI and
FSC MFI of Standard and
Uptake correction low vs
high
Fig. 4 TWIST1high BMSCs
have a high proliferation
capacity. a TWIST1 RT-
PCR results of Untreated,
TWIST1low and TWIST1high
populations, values
represent the mean ± SD
from duplicates.
b Morphology of BMSCs
5 days and 16 days after
being sorted. Scale bar
represents 100 lm. c Cell
numbers relative to t = 0 of
Untreated, TWIST1low and
TWIST1high were passaged
and counted on day 0, day 5,
day 10 and day 16
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fold difference after 3 passages) and, 16 days post
sorting, the TWIST1lowBMSCs stop growing while the
TWIST1high BMSCs were still expanding (data not
shown). This indicates that within a population of
BMSCs derived from one donor, the TWIST1high
expressing cells have a higher expansion rate com-
pared to the TWIST1low expressing cells.
Discussion
In this study, we evaluated the use of the SmartFlare
technique to detect TWIST1 expression at a single cell
level in living BMSCs. Multiple studies successfully
detected mRNA expression with the SmartFlare
technique (McClellan et al. 2015; Kronig et al. 2015;
Lahm et al. 2015; Seftor et al. 2014; Li et al. 2016).
However, two recent studies showed that different
SmartFlare probes were not able to specifically detect
their target mRNAs in cell lines and monocytes
(Czarnek and Bereta 2017; Yang et al. 2018). Here we
showed that SmartFlare is an effective tool to detect
TWIST1 gene expression in living BMSCs, but
differences in probe concentration, incubation time
and cellular uptake can influence the SmartFlare
sensitivity and possibly lead to misinterpretation of
the results.
We observed that specific detection of TWIST1
mRNA expression in BMSCs is possible already after
6 h of incubation with a concentration of 50 pM,
TWIST1-Cy3 probe. While most of the studies used
16 h (McClellan et al. 2015; Seftor et al. 2014; Li et al.
2016; Czarnek and Bereta 2017) or even a longer
incubation time (Kronig et al. 2015; Lahm et al. 2015;
Czarnek and Bereta 2017), we were not able to
specifically detect TWIST1 after 16 h incubation
(Figure S4). The SmartFlare technology was recently
applied in BMSCs (Li et al. 2016), but never for the
detection of TWIST1 expression. In our study a
different protocol was needed compared to the
RUNX2 and the SOX9 probes used by Li et al.
(2016). Possible explanations could be ascribed to
differences in culture conditions, origin of BMSCs or
binding efficiency of the probe to the target.
In addition, our data indicate that BMSCs can have
a high difference in probe uptake. We observed that
these differences strongly influence the TWIST1
SmartFlare specificity. This confirms confirms the
data previously reported where was shown that
SmartFlare intensity was affected by cellular uptake
in 293T cells (Czarnek and Bereta 2017). The
differences in uptake capacity can be explained by
differences in cell cycle stage between the BMSCs,
since endocytosis is reduced during mitosis (Fielding
et al. 2012). Here, we were able to overcome this
problem by correcting TWIST1 detection for the
cellular uptake based on Uptake probe intensity during
sorting. Next, we demonstrate that TWIST1high
expressing BMSCs have a higher expansion capacity
than TWIST1low expressing BMSCs derived from the
same donor. A population of BMSCs with a high
TWIST1 expression and a high proliferation rate have
already been reported by us and others (Isenmann et al.
2009; Cleary et al. 2017; Narcisi et al. 2015). Here, we
showed for the first time that within the same
population of BMSCs, the subpopulation of
TWIST1high expressing cells have a higher expansion
capacity than the TWIST1low expressing cells. Alter-
natively to the use of the uptake control, in a previous
report the ratio between two functional markers,
RUNX2 and SOX9, was applied (Li et al. 2016). This
indirect method could also be used, since it would
automatically take into account differences in uptake,
as these would not change the ratio, but only the
intensity of the individual signals.
Conclusion
In summary, our data indicate that for each probe and
cell type, a validation of the SmartFlare protocol is
necessary. Giving that, we were able to successfully
use the TWIST1 probe to detect TWIST1 mRNA in
living BMSCs and to sort TWIST1high BMSCs from a
heterogeneous population of cells. Overall, we showed
that SmartFlare is a promising tool to divide a
heterogeneous population of cells based on gene
expression in functionally different populations.
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